Document Detail


Clinical review: Clinical utility of TSH receptor antibodies.
MedLine Citation:
PMID:  23539719     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONTEXT: TSH receptor antibodies (TRAb) cause Graves' disease (GD) hyperthyroidism. Widely available TRAb measurement methods have been significantly improved recently. However, the role of TRAb measurement in the differential diagnosis of hyperthyroidism, the prediction of remission of GD hyperthyroidism, the prediction of fetal/neonatal thyrotoxicosis, and the clinical assessment of Graves' ophthalmopathy (GO) are controversial.
EVIDENCE ACQUISITION: We reviewed and analyzed the literature reporting primary data on the clinical use of TRAb. We focused our analyses on clinical studies analyzing third-generation TRAb assays.
EVIDENCE SYNTHESIS: The performance of TRAb in the differential diagnosis of overt hyperthyroidism is excellent, with sensitivity and specificity in the upper 90%. TRAb can accurately predict short-term relapses of hyperthyroidism after a course of antithyroid drugs but are less effective in predicting long-term relapses or remissions. Pregnancies in women with GD with negative TRAb are highly unlikely to result in fetal hyperthyroidism, whereas high titers of TRAb in pregnancy require careful fetal monitoring. GD patients with GO frequently have high TRAb levels. However, there are insufficient data to use the test to predict the clinical course of GO and response to treatment.
CONCLUSIONS: Third-generation TRAb assays are suitable in the differential diagnosis of hyperthyroidism. In GD, TRAb should be tested before deciding whether methimazole can be stopped. TRAb should be used in pregnant women with GD to assess the risk of fetal thyrotoxicosis. The use of TRAb in GO requires further studies.
Authors:
Giuseppe Barbesino; Yaron Tomer
Related Documents :
2214099 - Effects of medicaid eligibility expansion on prenatal care and pregnancy outcome in ten...
9348969 - Oral care during pregnancy.
9475129 - Safety behaviors of abused women after an intervention during pregnancy.
9793939 - Domestic violence in the pregnant patient: obstetric and behavioral interventions.
17613929 - Autoimmune hepatitis among fertile women: strategies during pregnancy and breastfeeding?
12200099 - Pregnancy planning and folic acid supplement use: results from a survey in quebec.
20618729 - Non-stress-related factors associated with maternal corticotrophin-releasing hormone (c...
8293589 - Viruses, bacteria, and protozoans in pregnancy: a sample of each.
21047579 - Venous thromboembolism in pregnancy.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review     Date:  2013-03-28
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  98     ISSN:  1945-7197     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  2013 Jun 
Date Detail:
Created Date:  2013-06-03     Completed Date:  2013-08-09     Revised Date:  2014-06-03    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2247-55     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Autoantibodies / blood*
Female
Graves Disease / diagnosis*
Graves Ophthalmopathy / diagnosis,  immunology
Humans
Maternal-Fetal Exchange
Pregnancy
Prognosis
Receptors, Thyrotropin / immunology*
Grant Support
ID/Acronym/Agency:
DK061659/DK/NIDDK NIH HHS; DK067555/DK/NIDDK NIH HHS; DK073681/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
0/Autoantibodies; 0/Receptors, Thyrotropin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Idiopathic adult growth hormone deficiency.
Next Document:  Humanized medium (h7H) allows long-term primary follicular thyroid cultures from human normal thyroi...